232 related articles for article (PubMed ID: 34356118)
21. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
22. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
23. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
[TBL] [Abstract][Full Text] [Related]
25. Screening and identification of key genes and pathways in metastatic uveal melanoma based on gene expression using bioinformatic analysis.
Xie J; Wu Z; Xu X; Liang G; Xu J
Medicine (Baltimore); 2020 Oct; 99(43):e22974. PubMed ID: 33120861
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
Yang G; Jian L; Lin X; Zhu A; Wen G
Dis Markers; 2019; 2019():1372571. PubMed ID: 31949544
[TBL] [Abstract][Full Text] [Related]
27. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H
Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405
[TBL] [Abstract][Full Text] [Related]
28. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis.
Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM
Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230
[TBL] [Abstract][Full Text] [Related]
29. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
[TBL] [Abstract][Full Text] [Related]
30. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
31. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.
Li C; Hong Z; Ou M; Zhu X; Zhang L; Yang X
Biomed Res Int; 2021; 2021():6673655. PubMed ID: 34734085
[TBL] [Abstract][Full Text] [Related]
32. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
33. Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma.
Zhang H; Zhong J; Tu Y; Liu B; Chen Z; Luo Y; Tang Y; Xiao F; Zhong J
Biomed Res Int; 2019; 2019():2615921. PubMed ID: 31950035
[TBL] [Abstract][Full Text] [Related]
34. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
35. Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis.
Wang S; Tao S; Liu Y; Shi Y; Liu M
J Egypt Natl Canc Inst; 2022 Dec; 34(1):55. PubMed ID: 36567425
[TBL] [Abstract][Full Text] [Related]
36. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
37. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
Sadegh K; Ahmadi A
IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
[TBL] [Abstract][Full Text] [Related]
38. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.
Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
[TBL] [Abstract][Full Text] [Related]
39. Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis.
Liu L; Yu Y; Hu LL; Dong QB; Hu F; Zhu LJ; Liang Q; Yu LL; Bao HH; Cheng XS
Med Sci Monit; 2021 Mar; 27():e928366. PubMed ID: 33741890
[TBL] [Abstract][Full Text] [Related]
40. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
